Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.2K
Overview of Secretory Vesicles01:33

Overview of Secretory Vesicles

8.8K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.8K
GTPases and their Regulation02:14

GTPases and their Regulation

2.4K
2.4K
GTPases and their Regulation02:14

GTPases and their Regulation

7.9K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complicated intra-abdominal fibromatosis masked by a perforated jejunal diverticulitis.

BMJ case reports·2026
Same author

Evaluating the Clinical Impact of the Direct-To-Test Neck Lump Referral Pathway. A Retrospective Review at a District General Hospital.

Head & neck·2026
Same author

Site-Selective C-H Sulfinamidation through Electron-Donor-Acceptor Complex Photoactivation and Radical Addition into Sulfinylamine Reagents.

Organic letters·2025
Same author

Mechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A).

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Author Correction: Structures of synaptic vesicle protein 2A and 2B bound to anticonvulsants.

Nature structural & molecular biology·2025
Same author

Discovery of UCB9386: A Potent, Selective, and Brain-Penetrant Nuak1 Inhibitor Suitable for <i>In Vivo</i> Pharmacological Studies.

Journal of medicinal chemistry·2024
Same journal

Preface.

Progress in medicinal chemistry·2025
Same journal

The rise of AlphaFold in drug design.

Progress in medicinal chemistry·2025
Same journal

Drug design strategies for the selective targeting of lung, liver and kidney.

Progress in medicinal chemistry·2025
Same journal

To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives.

Progress in medicinal chemistry·2024
Same journal

Another decade of antimalarial drug discovery: New targets, tools and molecules.

Progress in medicinal chemistry·2024
Same journal

Harnessing conformational drivers in drug design.

Progress in medicinal chemistry·2024
See all related articles

Related Experiment Video

Updated: May 4, 2026

Quantitative Measurement of &#947;-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
06:40

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

6.2K

γ-Secretase modulators: current status and future directions.

Adrian Hall1, Toshal R Patel2

  • 1Department of Chemistry, Discovery Research, Neuroscience and General Medicine Product Creation Unit, Eisai Ltd., EMEA Knowledge Centre, Mosquito Way, Hatfield, United Kingdom.

Progress in Medicinal Chemistry
|January 15, 2014
PubMed
Summary
This summary is machine-generated.

This review examines gamma-secretase modulators, focusing on key compounds, chemotypes, and chemical biology. It analyzes PK-PD relationships and clinical development status for future prospects.

Keywords:
Alzheimer’s diseaseγ-Secretaseγ-Secretase inhibitorsγ-Secretase modulators

More Related Videos

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by &#947;-Secretase
11:57

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Published on: June 24, 2025

733
Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
04:41

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

483

Related Experiment Videos

Last Updated: May 4, 2026

Quantitative Measurement of &#947;-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
06:40

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

6.2K
Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by &#947;-Secretase
11:57

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Published on: June 24, 2025

733
Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice
04:41

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

483

Area of Science:

  • Pharmacology and Medicinal Chemistry
  • Drug Discovery and Development

Background:

  • Gamma-secretase modulators are a key area of research.
  • Understanding their mechanisms and development is crucial.

Purpose of the Study:

  • To review the current status of gamma-secretase modulators.
  • To highlight key compounds, chemotypes, and chemical biology studies.
  • To analyze PK-PD relationships and clinical development.

Main Methods:

  • Comprehensive review of peer-reviewed literature.
  • Analysis of patent literature for completeness.
  • Focus on three main chemotypes: acids, imidazoles, and natural products.

Main Results:

  • Identification of key compounds and companies in the field.
  • Elucidation of ligand-binding sites through chemical biology.
  • Analysis of PK-PD relationships and challenges.

Conclusions:

  • Summary of clinical development status.
  • Comment on future prospects of gamma-secretase modulators.
  • Highlighting key issues and challenges in the field.